Mechanism Analysis of Strengthening Anti-cerebral Ischemia Injury of Chuanxiong Rhizoma Processed with Wine Based on UHPLC-Q-Orbitrap HRMS and Integrated Network Pharmacology
|更新时间:2022-05-18
|
Mechanism Analysis of Strengthening Anti-cerebral Ischemia Injury of Chuanxiong Rhizoma Processed with Wine Based on UHPLC-Q-Orbitrap HRMS and Integrated Network Pharmacology
增强出版
Chinese Journal of Experimental Traditional Medical FormulaeVol. 28, Issue 12, Pages: 164-173(2022)
PEI Ke,NING Yan,CAI Hao,et al.Mechanism Analysis of Strengthening Anti-cerebral Ischemia Injury of Chuanxiong Rhizoma Processed with Wine Based on UHPLC-Q-Orbitrap HRMS and Integrated Network Pharmacology[J].Chinese Journal of Experimental Traditional Medical Formulae,2022,28(12):164-173.
PEI Ke,NING Yan,CAI Hao,et al.Mechanism Analysis of Strengthening Anti-cerebral Ischemia Injury of Chuanxiong Rhizoma Processed with Wine Based on UHPLC-Q-Orbitrap HRMS and Integrated Network Pharmacology[J].Chinese Journal of Experimental Traditional Medical Formulae,2022,28(12):164-173. DOI: 10.13422/j.cnki.syfjx.20220146.
Mechanism Analysis of Strengthening Anti-cerebral Ischemia Injury of Chuanxiong Rhizoma Processed with Wine Based on UHPLC-Q-Orbitrap HRMS and Integrated Network Pharmacology增强出版
To analyze the differential components in water extract of Chuanxiong Rhizoma before and after processing with wine, and to explore the molecular mechanism of Chuanxiong Rhizoma processed with wine in enhancing anti-cerebral ischemia injury.
Method
2
Ultra high performance liquid chromatography tandem quadrupole orbitrap high resolution mass spectrometry (UHPLC-Q-Orbitrap HRMS) was used to qualitatively analyze the main chemical components in water extract of Chuanxiong Rhizoma based on the spectral information of compound, comparison of reference substance and references. The chemical pattern recognition method was used to screen the differential components of Chuanxiong Rhizoma before and after processing. Based on these differential components, the potential targets of differential components were predicted by online databases, and the related targets of cerebral ischemia were searched. Cytoscape 3.6.0 was used to establish the network diagram of differential components-action targets-diseases of Chuanxiong Rhizoma processed with wine. The protein-protein interaction (PPI) network of intersection targets was constructed by STRING 11.5. The potential targets of differential components against cerebral ischemia were analyzed by Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis through DAVID 6.8. At the same time, the chemical compounds with high relative content and increased peak area after wine processing were docked with their corresponding targets to verify the mechanism of enhanced effect after wine processing.
Result
2
A total of 71 chemical components were identified from Chuanxiong Rhizoma, 34 differential components and 603 potential targets were screened out. At the same time, a total of 769 disease targets and 60 intersection targets were obtained. Seven key targets were identified through PPI network analysis, including JUN, signal transducer and activator of transcription 3 (STAT3), mitogen-activated protein kinase 3 (MAPK3), interleukin-1
β
(IL-1
β
), vascular endothelial growth factor A (VEGFA), Caspase-3 (CASP3) and mtrix metalloproteinase 9 (MMP9). Tumor necrosis factor (TNF) signaling pathway was the main differential signaling pathway. The results of molecular docking showed that differential components (senkyunolide K, senkyunolide F, 3-
n
-butylphthalide,
Z
,
Z
′-6,8′,7,3′-diligustilide, ferulic acid and
Z
-ligustilide) and corresponding targets had good binding activities.
Conclusion
2
The synergistic mechanism of Chuanxiong Rhizoma processed with wine may be related to the enhanced inhibitory effect of inflammatory reaction.
LIU Z K , NG C F , SHIU H T , et al . A traditional Chinese formula composed of Chuanxiong Rhizoma and Gastrodiae Rhizoma(Da Chuanxiong formula) suppresses inflammatory response in LPS-induced RAW 264.7 cells through inhibition of NF- κ B pathway [J]. J Ethnopharmacol , 2017 , 196 : 20 - 28 .
HUANG J , LU X Q , ZHANG C , et al . Anti-inflammatory ligustilides from Ligusticum chuanxiong Hort .[J]. Fitoterapia , 2013 , 91 : 21 - 27 .
HUANG C , CAO X Y , CHEN X F , et al . A pectic polysaccharide from Ligusticum chuanxiong promotes intestine antioxidant defense in aged mice [J]. Carbohydr Polym , 2017 , 174 : 915 - 922 .
LU C , ZHANG J , SHI X P , et al . Neuroprotective effects of tetramethylpyrazine against dopaminergic neuron injury in a rat model of Parkinson′s disease induced by MPTP [J]. Int J Biol Sci , 2014 , 10 ( 4 ): 350 - 357 .
NING Y , PEI K , CAO G , et al . Comparative study on pharmacokinetics of four active compounds in rat plasma after oral administration of raw and wine processed Chuanxiong Rhizoma [J]. Molecules , 2019 , 25 ( 1 ): E93 .
ZHANG L , ZHANG W , CHEN W , et al . Simultaneous determination of five bioactive constituents in Rhizoma Chuanxiong by capillary electrophoresis with a carbon nanotube-polydimethylsiloxane composite electrode [J]. J Pharm Biomed Anal , 2016 , 131 : 107 - 112 .
LIANG Z , WU G , FAN C , et al . The emerging role of signal transducer and activator of transcription 3 in cerebral ischemic and hemorrhagic stroke [J]. Prog Neurobiol , 2016 , 137 : 1 - 16 .
HOVHANNESYAN R A , HOVHANNISYAN I G . Platelet aggregation and interleukins indicators impacting the outcomes of ischemic stroke [J]. J Stroke Cerebrovasc Dis , 2019 , 28 : 2038 - 2044 .
Investigation of Potential Pharmacodynamic Substances and Mechanism of Gardeniae Fructus in Treatment of Ischemic Stroke Based on HPLC-Q-TOF-MS/MS and Network Pharmacology
Mahoniae Caulis Alkaloids Ameliorate Depression by Regulating Synaptic Plasticity via cAMP Pathway
Analysis of Potential Active Components and Molecular Mechanism of Baoxin Granules Regulating Ferroptosis in Treatment of Heart Failure
Effect and Mechanism of Angelicae Sinensis Radix-Polygonati Rhizoma Herb Pair in Treatment of Simple Obesity
Screening of Anti-breast Cancer Active Ingredients in Famous Classical Formula Yanghetang
Related Author
Ya GAO
Yun WANG
Ying-hao ZHENG
Meng-yu XIA
Cun ZHANG
Cheng-yong WANG
HE Junhui
JIA Chunlian
Related Institution
School of Pharmacy,Anhui University of Chinese Medicine,Heifei
Institute of Chinese Materia Medica,China Academy of Chinese Medical Sciences
School of Pharmacy, Henan University of Chinese Medicine
Key Laboratory of Chemistry and Engineering of Forest Products, National Ethnic Affairs Commission, Guangxi Key Laboratory of Chemistry and Engineering of Forest Products/Guangxi Collaborative Innovation Center for Chemistry and Engineering of Forest Products, School of Chemistry and Chemical Engineering, Guangxi Minzu University
Guangxi Key Laboratory of Chinese Medicine Quality Standard, Guangxi Institute of Chinese Medicine and Pharmaceutical Science